BOTULINUM NEUROTOXINS TYPE A AND B
SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o.,
would like to kindly invite you to negotiate rights acquisition to the
documentation of development of the method for the production and purification
of botulinum neurotoxins type A and B.
The
project was carried out within Operational Programme Innovative Economy
2007-2013, Action 1.4 “Support for special projects” based on co-financing
agreement POIG.01.04.00-14-008/13. In attachment you can find detailed
description of this project.
SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o.,
would like to kindly invite you to negotiate rights acquisition to the
documentation of development of the method for the production and purification
of botulinum neurotoxins type A and B.
The
project was carried out within Operational Programme Innovative Economy
2007-2013, Action 1.4 “Support for special projects” based on co-financing
agreement POIG.01.04.00-14-008/13. In attachment you can find detailed
description of this project.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance